Thursday, May 2, 2019

Glenmark Pharma expects up to 14 % growth in India revenues in FY20

Glenmark Pharma expects up to 14 % growth in India revenues in FY20 Glenmark reported Rs 2514 crore revenues from India in FY 18 against Rs 2303 crore in the previous year growth of 10 percent.

from Moneycontrol Business News http://bit.ly/2DGxoGI

No comments:

Post a Comment

Nifty eyes relief rally on tariff hopes, FIIs remain a drag

Markets anticipate a rebound early in the shortened week following news of potential tariff removal on India. Despite oversold conditions, a...